المؤلفون: Signori A; Department of Health Sciences, Section of Biostatistics, University of Genova, Genoa, Italy alessio.signori@medicina.unige.it., Ponzano M; Department of Health Sciences, Section of Biostatistics, University of Genova, Genoa, Italy., Kalincik T; Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia.; Department of Neurology, Royal Melbourne Hospital, Melbourne, Victoria, Australia., Ozakbas S; Dokuz Eylul University, İzmir, Turkey., Horakova D; Department of Neurology and Center of Clinical Neuroscience, Charles University in Prague, 1st Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic., Kubala Havrdova E; Department of Neurology and Center of Clinical Neuroscience, Charles University in Prague, 1st Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic., Alroughani R; Amiri Hospital, Kuwait City, Kuwait., Patti F; Department of Neuroscience, University of Catania Department of Surgical and Medical Sciences and Advanced Technologies 'G.F. Ingrassia', Catania, Italy., Kuhle J; Department of Neurology, University Hospital Basel, Basel, Switzerland., Izquierdo G; Hospital Universitario Virgen Macarena, Seville, Spain., Eichau S; Hospital Universitario Virgen Macarena, Seville, Spain., Yamout B; American University of Beirut Medical Center, Beirut, Lebanon., Khoury SJ; Nehme and Therese Tohme Multiple Sclerosis Center, American University of Beirut Medical Center, Beirut, Lebanon.; American University of Beirut, Beirut, Lebanon., Karabudak R; Department of Neurology, Hacettepe University Faculty of Medicine, Ankara, Turkey., Grammond P; Hotel-Dieu de Levis, Levis, Quebec, Canada., Duquette P; CHUM MS Center and Department of Neuroscience, Université de Montréal, Montreal, Québec, Canada., Roos I; Clinical Outcomes Research Unit, The University of Melbourne Department of Medicine Royal Melbourne Hospital, Parkville, Victoria, Australia., Butzkueven H; Monash University Central Clinical School, Melbourne, Victoria, Australia.; Alfred Hospital, Melbourne, Victoria, Australia., van der Walt A; Monash University Central Clinical School, Melbourne, Victoria, Australia.; Alfred Hospital, Melbourne, Victoria, Australia., Sormani MP; Department of Health Sciences, Section of Biostatistics, University of Genova, Genoa, Italy.; Istituto di Ricovero e Cura a Carattere Scientifico, Ospedale Policlinico San Martino, Genoa, Italy.

المصدر: Journal of neurology, neurosurgery, and psychiatry [J Neurol Neurosurg Psychiatry] 2024 Jun 17; Vol. 95 (7), pp. 620-625. Date of Electronic Publication: 2024 Jun 17.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 2985191R Publication Model: Electronic Cited Medium: Internet ISSN: 1468-330X (Electronic) Linking ISSN: 00223050 NLM ISO Abbreviation: J Neurol Neurosurg Psychiatry Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Sclerosis, Relapsing-Remitting*/drug therapy , Fingolimod Hydrochloride*/therapeutic use , Interferon beta-1a*/therapeutic use , Registries* , Randomized Controlled Trials as Topic*, Humans ; Male ; Female ; Adult ; Middle Aged ; Immunosuppressive Agents/therapeutic use ; Treatment Outcome

المؤلفون: Cutillo G; Neurology Unit, IRCCS San Raffaele Scientific Institute, Via Olgettina 60, 20132, Milan, Italy.; Neurophysiology Service, IRCCS San Raffaele Scientific Institute, Milan, Italy.; Vita-Salute San Raffaele University, Milan, Italy., Rubin M; Neurology Unit, IRCCS San Raffaele Scientific Institute, Via Olgettina 60, 20132, Milan, Italy.; Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.; Vita-Salute San Raffaele University, Milan, Italy., d'Amore G; Neurology Unit, IRCCS San Raffaele Scientific Institute, Via Olgettina 60, 20132, Milan, Italy.; Neurophysiology Service, IRCCS San Raffaele Scientific Institute, Milan, Italy.; Vita-Salute San Raffaele University, Milan, Italy., Malcangi M; Neurology Unit, IRCCS San Raffaele Scientific Institute, Via Olgettina 60, 20132, Milan, Italy.; Vita-Salute San Raffaele University, Milan, Italy., Vezzulli PQ; Neuroradiology Unit and High Field MRI Center, IRCCS San Raffaele Scientific Institute, Milan, Italy., Ferrè L; Laboratory of Human Genetics of Neurological Disorders, Division of Neuroscience, Institute of Experimental Neurology, IRCCS San Raffaele Scientific Institute, Milan, Italy.; Neurorehabilitation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy., Martinelli V; Neurology Unit, IRCCS San Raffaele Scientific Institute, Via Olgettina 60, 20132, Milan, Italy., Esposito F; Neurology Unit, IRCCS San Raffaele Scientific Institute, Via Olgettina 60, 20132, Milan, Italy.; Laboratory of Human Genetics of Neurological Disorders, Division of Neuroscience, Institute of Experimental Neurology, IRCCS San Raffaele Scientific Institute, Milan, Italy., Filippi M; Neurology Unit, IRCCS San Raffaele Scientific Institute, Via Olgettina 60, 20132, Milan, Italy. filippi.massimo@hsr.it.; Neurophysiology Service, IRCCS San Raffaele Scientific Institute, Milan, Italy. filippi.massimo@hsr.it.; Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy. filippi.massimo@hsr.it.; Neurorehabilitation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy. filippi.massimo@hsr.it.; Vita-Salute San Raffaele University, Milan, Italy. filippi.massimo@hsr.it.

المصدر: Journal of neurology [J Neurol] 2024 May; Vol. 271 (5), pp. 2225-2229. Date of Electronic Publication: 2024 Feb 22.

نوع المنشور: Letter; Case Reports

بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 0423161 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1459 (Electronic) Linking ISSN: 03405354 NLM ISO Abbreviation: J Neurol Subsets: MEDLINE

مواضيع طبية MeSH: Posterior Leukoencephalopathy Syndrome*/chemically induced , Posterior Leukoencephalopathy Syndrome*/diagnostic imaging, Humans ; Female ; Multiple Sclerosis/drug therapy ; Multiple Sclerosis/complications ; Multiple Sclerosis/diagnostic imaging ; Interferon beta-1a/adverse effects ; Adult ; Magnetic Resonance Imaging ; Immunologic Factors/adverse effects

عنوان ترانسليتريتد: Dolgosrochnye dannye po effektivnosti i bezopasnosti preparata sampeginterferon-β1a u patsientov s remittiruyushchim rasseyannym sklerozom: rezul'taty 104-nedel'nogo randomizirovannogo dvoinogo slepogo klinicheskogo issledovaniya.

المؤلفون: Boyko AN; Pirogov National Medical Research University, Moscow, Russia.; Federal Center for Brain Research and Neurotechnologies, Moscow, Russia., Bakhtiyarova KZ; Kuvatov Republican Clinical Hospital, Ufa, Russia., Boyko OV; Federal Center for Brain Research and Neurotechnologies, Moscow, Russia., Dudin VA; Center for Cardiology and Neurology, Kirov, Russia., Zaslavskii LG; Leningrad Regional Clinical Hospital, St. Petersburg, Russia., Malkova NA; Regional Clinical Hospital, Novosibirsk, Russia., Parshina EV; Semashko Regional Clinical Hospital, Nizhny Novgorod, Russia., Poverennova IY; Seredavin Regional Clinical Hospital, Samara, Russia., Sivertseva SA; Medical and Sanitary Unit «Neftyanik», Tyumen, Russia., Totolyan NA; Pavlov First Saint Petersburg State Medical University, St. Petersburg, Russia., Shchur SG; Filatov Moscow City Clinical Hospital No. 15, Moscow, Russia., Khabirov FA; Republican Clinical Neurological Center, Kazan, Russia., Goncharova ZA; Rostov State Medical University, Rostov-on-Don, Russia., Zakharova MN; Research Center of Neurology, Moscow, Russia., Bolsun DD; JSC «BIOCAD», St. Petersburg, Russia., Zinkina-Orikhan AV; JSC «BIOCAD», St. Petersburg, Russia., Lin'kova YN; JSC «BIOCAD», St. Petersburg, Russia., Chernovskaya TV; JSC «BIOCAD», St. Petersburg, Russia., Porozova AA; JSC «BIOCAD», St. Petersburg, Russia.

المصدر: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2023; Vol. 123 (2), pp. 52-59.

نوع المنشور: Randomized Controlled Trial; English Abstract; Journal Article

بيانات الدورية: Publisher: Media Sfera Country of Publication: Russia (Federation) NLM ID: 9712194 Publication Model: Print Cited Medium: Print ISSN: 1997-7298 (Print) Linking ISSN: 19977298 NLM ISO Abbreviation: Zh Nevrol Psikhiatr Im S S Korsakova Subsets: MEDLINE

مواضيع طبية MeSH: Interferon beta-1a*/administration & dosage , Interferon beta-1a*/adverse effects , Interferon beta-1a*/therapeutic use , Multiple Sclerosis, Relapsing-Remitting*/diagnostic imaging , Multiple Sclerosis, Relapsing-Remitting*/drug therapy, Humans ; Double-Blind Method ; Multiple Sclerosis/drug therapy ; Recurrence ; Treatment Outcome ; Adolescent ; Young Adult ; Adult ; Middle Aged

المؤلفون: Abdelgaied MY; Clinical Pharmacy Department, Faculty of Pharmacy and Biotechnology, The German University in Cairo (GUC), Cairo, Egypt.; Clinical Pharmacology and Pharmacogenomics Research Group, Pharmacology and Toxicology Department, Faculty of Pharmacy and Biotechnology, German University in Cairo, Cairo, Egypt.; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, T6G 2E1, Canada., Rashad MH; Neurology Department, Faculty of Medicine, Al-Azhar University, Cairo, Egypt., El-Tayebi HM; Clinical Pharmacology and Pharmacogenomics Research Group, Pharmacology and Toxicology Department, Faculty of Pharmacy and Biotechnology, German University in Cairo, Cairo, Egypt., Solayman MH; Clinical Pharmacy Department, Faculty of Pharmacy and Biotechnology, The German University in Cairo (GUC), Cairo, Egypt. mohamed.solayman@guc.edu.eg.; Clinical Pharmacy Department, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt. mohamed.solayman@guc.edu.eg.

المصدر: Journal of neurology [J Neurol] 2024 Mar; Vol. 271 (3), pp. 1124-1132. Date of Electronic Publication: 2023 Dec 09.

نوع المنشور: Randomized Controlled Trial; Clinical Trial, Phase II; Journal Article

بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 0423161 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1459 (Electronic) Linking ISSN: 03405354 NLM ISO Abbreviation: J Neurol Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Sclerosis*/drug therapy , Multiple Sclerosis, Relapsing-Remitting*/diagnostic imaging , Multiple Sclerosis, Relapsing-Remitting*/drug therapy , Multiple Sclerosis, Relapsing-Remitting*/pathology, Humans ; Adjuvants, Immunologic/therapeutic use ; Chronic Disease ; Interferon beta-1a/therapeutic use ; Prospective Studies ; Recurrence ; Treatment Outcome

المؤلفون: Kappos L; Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital and University of Basel, Basel, Switzerland. ludwig.kappos@usb.ch., Traboulsee A; Department of Medicine (Neurology), University of British Columbia, Vancouver, BC, Canada., Li DKB; Department of Radiology and Medicine (Neurology), University of British Columbia, Vancouver, BC, Canada., Bar-Or A; Center for Neuroinflammation and Experimental Therapeutics, and Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Barkhof F; VU University Medical Centre, Amsterdam, The Netherlands.; UCL Institutes of Biomedical Engineering and Neurology, London, UK., Montalban X; Department of Neurology-Neuroimmunology, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d'Hebron, Barcelona, Spain., Leppert D; Departments of Medicine, Biomedicine and Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland., Baldinotti A; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Schneble HM; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Koendgen H; F. Hoffmann-La Roche Ltd, Basel, Switzerland.; UCB Farchim SA, Bulle, Switzerland., Sauter A; F. Hoffmann-La Roche Ltd, Basel, Switzerland.; Janssen Pharmaceuticals, Allschwil, Basel-Landschaft, Switzerland., Wang Q; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Hauser SL; UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, USA.

المصدر: Journal of neurology [J Neurol] 2024 Feb; Vol. 271 (2), pp. 642-657. Date of Electronic Publication: 2023 Oct 31.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 0423161 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1459 (Electronic) Linking ISSN: 03405354 NLM ISO Abbreviation: J Neurol Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal, Humanized*/therapeutic use , Multiple Sclerosis, Relapsing-Remitting*/drug therapy, Humans ; Immunologic Factors/therapeutic use ; Interferon beta-1a/therapeutic use ; Clinical Trials, Phase II as Topic ; Randomized Controlled Trials as Topic

المؤلفون: Signori A; Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy. Electronic address: alessio.signori@unige.it., Bovis F; Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy., Schiavetti I; Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy., Ponzano M; Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy., Freedman MS; University of Ottawa, Department of Medicine and the Ottawa Hospital Research Institute, Ottawa, ON, Canada., Marhardt K; Merck Gesellschaft mbH, Vienna, Austria (an affiliate of Merck KGaA)., Alexandri N; Merck Healthcare KGaA, Darmstadt, Germany., Sormani MP; Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy; Ospedale Policlinico San Martino IRCCS, Genoa, Italy.

المصدر: Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2023 Nov; Vol. 79, pp. 104945. Date of Electronic Publication: 2023 Aug 20.

نوع المنشور: Randomized Controlled Trial; Journal Article

بيانات الدورية: Publisher: Elsevier B. V Country of Publication: Netherlands NLM ID: 101580247 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-0356 (Electronic) Linking ISSN: 22110348 NLM ISO Abbreviation: Mult Scler Relat Disord Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Sclerosis*/drug therapy , Multiple Sclerosis, Relapsing-Remitting*/drug therapy, Humans ; Interferon-beta/therapeutic use ; Interferon beta-1a/therapeutic use ; Injections, Subcutaneous ; Treatment Outcome

المؤلفون: Gonzalez-Lorenzo M; Laboratorio di Metodologia delle revisioni sistematiche e produzione di Linee Guida, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy., Ridley B; IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy., Minozzi S; Department of Epidemiology, Lazio Regional Health Service, Rome, Italy., Del Giovane C; Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.; Cochrane Italy, Department of Medical and Surgical Sciences for Children and Adults, University-Hospital of Modena and Reggio Emilia, Modena, Italy., Peryer G; School of Health Sciences, University of East Anglia (UEA), Norwich, UK., Piggott T; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.; Department of Family Medicine, Queens University, Kingston, Ontario, Canada., Foschi M; Department of Neuroscience, Multiple Sclerosis Center - Neurology Unit, S.Maria delle Croci Hospital, AUSL Romagna, Ravenna, Italy.; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy., Filippini G; Scientific Director's Office, Carlo Besta Foundation and Neurological Institute, Milan, Italy., Tramacere I; Department of Research and Clinical Development, Scientific Directorate, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy., Baldin E; IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy., Nonino F; IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.

المصدر: The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2024 Jan 04; Vol. 1. Cochrane AN: CD011381. Date of Electronic Publication: 2024 Jan 04.

نوع المنشور: Meta-Analysis; Systematic Review; Journal Article; Review

بيانات الدورية: Publisher: Wiley Country of Publication: England NLM ID: 100909747 Publication Model: Electronic Cited Medium: Internet ISSN: 1469-493X (Electronic) Linking ISSN: 13616137 NLM ISO Abbreviation: Cochrane Database Syst Rev Subsets: MEDLINE

مواضيع طبية MeSH: Immunosuppressive Agents*/therapeutic use , Multiple Sclerosis, Relapsing-Remitting*/drug therapy, Adult ; Humans ; Glatiramer Acetate/therapeutic use ; Interferon beta-1a/therapeutic use ; Fingolimod Hydrochloride/therapeutic use ; Natalizumab/therapeutic use ; Interferon beta-1b/therapeutic use ; Cladribine/therapeutic use ; Alemtuzumab/therapeutic use ; Dimethyl Fumarate/therapeutic use ; Daclizumab/therapeutic use ; Network Meta-Analysis ; Immunologic Factors/therapeutic use ; Recurrence

المؤلفون: Moccia M; Multiple Sclerosis Unit, Policlinico Federico II University Hospital of Naples, Naples, Italy. marcello.moccia@unina.it., Santoni L, Vaccari I, Affinito G, Caliendo D, Rubba F, Lanzillo R, Triassi M, Brescia Morra V, Palladino R

المصدر: European review for medical and pharmacological sciences [Eur Rev Med Pharmacol Sci] 2024 Jan; Vol. 28 (1), pp. 411-418.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Verduci Country of Publication: Italy NLM ID: 9717360 Publication Model: Print Cited Medium: Internet ISSN: 2284-0729 (Electronic) Linking ISSN: 11283602 NLM ISO Abbreviation: Eur Rev Med Pharmacol Sci Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Sclerosis, Relapsing-Remitting*/drug therapy , Multiple Sclerosis*/drug therapy , Polyethylene Glycols*, Female ; Humans ; Aged ; Adult ; Middle Aged ; Glatiramer Acetate/therapeutic use ; Interferon beta-1a/therapeutic use ; Interferon-beta/therapeutic use

المؤلفون: Lotfi R; Biological Engineering Laboratory, Faculty of Sciences and Techniques, Sultan Moulay Slimane University, Beni Mellal, Morocco. Electronic address: r.lotfi@usms.ma., El Kardoudi A; Biological Engineering Laboratory, Faculty of Sciences and Techniques, Sultan Moulay Slimane University, Beni Mellal, Morocco., Chigr F; Biological Engineering Laboratory, Faculty of Sciences and Techniques, Sultan Moulay Slimane University, Beni Mellal, Morocco.

المصدر: Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2024 Jan; Vol. 81, pp. 105347. Date of Electronic Publication: 2023 Dec 02.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier B. V Country of Publication: Netherlands NLM ID: 101580247 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-0356 (Electronic) Linking ISSN: 22110348 NLM ISO Abbreviation: Mult Scler Relat Disord Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Sclerosis*/drug therapy , Multiple Sclerosis*/epidemiology , Multiple Sclerosis, Relapsing-Remitting*/drug therapy , Multiple Sclerosis, Relapsing-Remitting*/epidemiology, Humans ; Female ; Morocco/epidemiology ; Interferon beta-1a/therapeutic use ; Recurrence

المؤلفون: Mattiesing RM; MS Center Amsterdam, Department of Radiology and Nuclear Medicine, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam UMC Location VUmc, Amsterdam, The Netherlands., Kramer E; MS Center Amsterdam, Department of Radiology and Nuclear Medicine, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam UMC Location VUmc, Amsterdam, The Netherlands., Strijbis EM; MS Center Amsterdam, Department of Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam UMC Location VUmc, Amsterdam, The Netherlands., Brouwer I; MS Center Amsterdam, Department of Radiology and Nuclear Medicine, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam UMC Location VUmc, Amsterdam, The Netherlands., van Schijndel RA; MS Center Amsterdam, Department of Radiology and Nuclear Medicine, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam UMC Location VUmc, Amsterdam, The Netherlands., Gentile G; Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy/SIENA Imaging SRL, Siena, Italy., Battaglini M; Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy/SIENA Imaging SRL, Siena, Italy., De Stefano N; Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy., Uitdehaag BM; MS Center Amsterdam, Department of Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam UMC Location VUmc, Amsterdam, The Netherlands., Barkhof F; MS Center Amsterdam, Department of Radiology and Nuclear Medicine, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam UMC Location VUmc, Amsterdam, The Netherlands.; Queen Square Institute of Neurology and Centre for Medical Image Computing, University College London, London, UK., Vrenken H; MS Center Amsterdam, Department of Radiology and Nuclear Medicine, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam UMC Location VUmc, Amsterdam, The Netherlands., Schoonheim MM; MS Center Amsterdam, Department of Anatomy and Neurosciences, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam UMC Location VUmc, Amsterdam, The Netherlands.

المصدر: Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2024 Jan; Vol. 30 (1), pp. 44-54. Date of Electronic Publication: 2023 Nov 29.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: SAGE Publications Country of Publication: England NLM ID: 9509185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0970 (Electronic) Linking ISSN: 13524585 NLM ISO Abbreviation: Mult Scler Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Sclerosis*/diagnostic imaging , Multiple Sclerosis*/drug therapy , Multiple Sclerosis*/pathology, Humans ; Brain/diagnostic imaging ; Brain/pathology ; Interferon beta-1a ; Disease Progression ; Atrophy/pathology ; Magnetic Resonance Imaging/methods